Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Labenz

Showing results (121-130 of 144) with videos related to

Pageof 15
Sort By:
JHEP Reports : Innovation in Hepatology|April 2, 2025
QuickStroop for screening for minimal hepatic encephalopathy in patients with cirrhosisChristian Labenz, Simon J Gairing, Leonard Kaps, et al.
Journal of Hepatology|April 18, 2025
Albumin infusion in hepatorenal syndrome-acute kidney injury: New evidence challenges recent consensusPaolo Angeli, Christian Labenz, Salvatore Piano, et al.
BMJ Open|September 19, 2025
Evaluating a population-based screening programme for early detection of liver fibrosis and cirrhosis in primary care in Germany: a cost assessment studyJulia Ortner, Reyn Van Ewijk, Louis Velthuis, et al.
Hepatology Communications|February 24, 2025
MCAM is a prognostic biomarker in patients with liver cirrhosis and HCCEva Stockinger, Hendrik Luxenburger, Dominik Bettinger, et al.
Zeitschrift Fur Gastroenterologie|November 15, 2022
Bevacizumab in combination with octreotide rescues a patient with liver cirrhosis, GAVE syndrome and refractory hemorrhage - a case reportSimon Johannes Gairing, Eva Maria Schleicher, Lukas Müller, et al.
Journal of Internal Medicine|November 20, 2023
Minimal hepatic encephalopathy is associated with a higher risk of overt hepatic encephalopathy and poorer survivalSimon Johannes Gairing, Chiara Mangini, Lisa Zarantonello, et al.
Hepatology Communications|May 3, 2024
PHES scores have limited impact on the risk of overt HE in patients with minimal HESimon Johannes Gairing, Chiara Mangini, Lisa Zarantonello, et al.
Medcomm|November 7, 2025
Neurofilament Light Chains in Serum Predict Post-Transjugular Intrahepatic Portosystemic Shunt Hepatic EncephalopathyChristian Labenz, Eva Maria Schleicher, Myriam Meineck, et al.
Journal of Clinical Medicine|May 28, 2022
Influence of Advanced Organ Support (ADVOS) on Cytokine Levels in Patients with Acute-on-Chronic Liver Failure (ACLF)Leonard Kaps, Eva Maria Schleicher, Carolina Medina Montano, et al.
Alimentary Pharmacology & Therapeutics|August 2, 2025
Impact of Frailty on the Prognosis of Patients With Liver Cirrhosis Undergoing Insertion of a TIPSMartin Andreas Kabelitz, Simon Johannes Gairing, Anja Tiede, et al.
Pageof 15

Showing results (121-130 of 144) with videos related to

Sort By:
Pageof 15
JHEP Reports : Innovation in Hepatology|April 2, 2025
QuickStroop for screening for minimal hepatic encephalopathy in patients with cirrhosisChristian Labenz, Simon J Gairing, Leonard Kaps, et al.
Journal of Hepatology|April 18, 2025
Albumin infusion in hepatorenal syndrome-acute kidney injury: New evidence challenges recent consensusPaolo Angeli, Christian Labenz, Salvatore Piano, et al.
BMJ Open|September 19, 2025
Evaluating a population-based screening programme for early detection of liver fibrosis and cirrhosis in primary care in Germany: a cost assessment studyJulia Ortner, Reyn Van Ewijk, Louis Velthuis, et al.
Hepatology Communications|February 24, 2025
MCAM is a prognostic biomarker in patients with liver cirrhosis and HCCEva Stockinger, Hendrik Luxenburger, Dominik Bettinger, et al.
Zeitschrift Fur Gastroenterologie|November 15, 2022
Bevacizumab in combination with octreotide rescues a patient with liver cirrhosis, GAVE syndrome and refractory hemorrhage - a case reportSimon Johannes Gairing, Eva Maria Schleicher, Lukas Müller, et al.
Journal of Internal Medicine|November 20, 2023
Minimal hepatic encephalopathy is associated with a higher risk of overt hepatic encephalopathy and poorer survivalSimon Johannes Gairing, Chiara Mangini, Lisa Zarantonello, et al.
Hepatology Communications|May 3, 2024
PHES scores have limited impact on the risk of overt HE in patients with minimal HESimon Johannes Gairing, Chiara Mangini, Lisa Zarantonello, et al.
Medcomm|November 7, 2025
Neurofilament Light Chains in Serum Predict Post-Transjugular Intrahepatic Portosystemic Shunt Hepatic EncephalopathyChristian Labenz, Eva Maria Schleicher, Myriam Meineck, et al.
Journal of Clinical Medicine|May 28, 2022
Influence of Advanced Organ Support (ADVOS) on Cytokine Levels in Patients with Acute-on-Chronic Liver Failure (ACLF)Leonard Kaps, Eva Maria Schleicher, Carolina Medina Montano, et al.
Alimentary Pharmacology & Therapeutics|August 2, 2025
Impact of Frailty on the Prognosis of Patients With Liver Cirrhosis Undergoing Insertion of a TIPSMartin Andreas Kabelitz, Simon Johannes Gairing, Anja Tiede, et al.
Pageof 15